Browse by Journal

Rezig, A. O.M. et al. (2025) Neutrophil-to-lymphocyte ratio: association with congestion, inflammation, and mortality in ambulatory patients with heart failure. ESC Heart Failure, 12(3), pp. 1571-1582. (doi: 10.1002/ehf2.15240) (PMID:40024803)

García‐Bolao, I. et al. (2025) Real‐world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry. ESC Heart Failure, 12(3), pp. 1832-1847. (doi: 10.1002/ehf2.15190) (PMID:39722592)

Bahar, J. et al. (2025) Outpatient treatment of decompensated heart failure: a systematic review and study level meta-analysis. ESC Heart Failure, 12(2), pp. 761-769. (doi: 10.1002/ehf2.14841) (PMID:39013806)

Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)

Grobbee, Diederick E., Filippatos, Gerasimos, Desai, Nihar R., Coats, Andrew J.S., Pinto, Fausto, Rosano, Giuseppe M.C., Cleland, John ORCID: https://orcid.org/0000-0002-1471-7016, Kammerer, Jennifer and Ramirez de Arellano, Antonio (2024) Epidemiology and risk factors for hyperkalaemia in heart failure. ESC Heart Failure, 11(4), pp. 1821-1840. (doi: 10.1002/ehf2.14661) (PMID:38439165) (PMCID:PMC11287317)

Docherty, Kieran Francis ORCID: https://orcid.org/0000-0002-5446-9969, McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975, Kalra, Paul, Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016, Lang, Ninian N. ORCID: https://orcid.org/0000-0001-8441-6887, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496, Robertson, Michele and Ford, Ian ORCID: https://orcid.org/0000-0001-5927-1823 (2024) Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction. ESC Heart Failure, 11(4), pp. 1875-1879. (doi: 10.1002/ehf2.14742) (PMID:38549192) (PMCID:PMC11287326)

Cuthbert, J. J. et al. (2024) Medicines optimization prior to discharge in patients admitted to hospital with heart failure. ESC Heart Failure, 11(2), pp. 950-961. (doi: 10.1002/ehf2.14638) (PMID:38229241) (PMCID:PMC10966249)

Butt, J. H. et al. (2024) Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan. ESC Heart Failure, 11(1), pp. 65-77. (doi: 10.1002/ehf2.14558) (PMID:37813587) (PMCID:PMC10804200)

Santos-Ferreira, D. et al. (2024) Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial. ESC Heart Failure, 11(1), pp. 209-218. (doi: 10.1002/ehf2.14465) (PMID:37939716) (PMCID:PMC10804163)

Abdin, Amr, Komajda, Michel, Borer, Jeffrey S., Ford, Ian ORCID: https://orcid.org/0000-0001-5927-1823, Tavazzi, Luigi, Batailler, Cécile, Swedberg, Karl, Rosano, Giuseppe M.C., Mahfoud, Felix and Böhm, Michael (2023) Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial). ESC Heart Failure, 10(5), pp. 2895-2902. (doi: 10.1002/ehf2.14455) (PMID:37427483) (PMCID:PMC10567656)

Graham, Fraser J., Pellicori, Pierpaolo ORCID: https://orcid.org/0000-0001-7175-0464, Masini, Gabriele, Cuthbert, Joseph J., Clark, Andrew L. and Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016 (2023) Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. ESC Heart Failure, 10(5), pp. 2826-2836. (doi: 10.1002/ehf2.14438) (PMID:37400990) (PMCID:PMC10567655)

Jankowska, E. A. et al. (2023) Optimizing outcomes in heart failure: 2022 and beyond. ESC Heart Failure, 10(4), pp. 2159-2169. (doi: 10.1002/ehf2.14363) (PMID:37060168) (PMCID:PMC10375115)

Leo, Vincenzo C., Kazmi, Syed, Brownrigg, Jack, Araghi, Marzieh, Sarna, Harpreet S., Pellicori, Pierpaolo ORCID: https://orcid.org/0000-0001-7175-0464, Cuthbert, Joe, Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016 and Clark, Andrew L. (2023) Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis. ESC Heart Failure, 10(2), pp. 1492-1496. (doi: 10.1002/ehf2.14315) (PMID:36811158) (PMCID:PMC10053180)

Tardif, J.‐C. et al. (2023) Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure. ESC Heart Failure, 10(2), pp. 1066-1076. (doi: 10.1002/ehf2.14268) (PMID:36564955) (PMCID:PMC10053160)

McAndrew, Debra J., Lake, Hannah A., Zervou, Sevasti, Schwedhelm, Edzard, Schneider, Jurgen E., Neubauer, Stefan and Lygate, Craig A. ORCID: https://orcid.org/0000-0001-6079-0284 (2023) Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure. ESC Heart Failure, 10(1), pp. 189-199. (doi: 10.1002/ehf2.14183) (PMID:36178450) (PMCID:PMC9871656)

Monzo, L. et al. (2022) Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial. ESC Heart Failure, 9(6), pp. 4352-4357. (doi: 10.1002/ehf2.14086) (PMID:36065795) (PMCID:PMC9773649)

Bracun, V. et al. (2022) Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence. ESC Heart Failure, 9(6), pp. 4167-4176. (doi: 10.1002/ehf2.14120) (PMID:36088651) (PMCID:PMC9773704)

Kazmi, Syed, Kambhampati, Chandrasekhar, Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016, Cuthbert, Joe, Kazmi, Khurram Shehzad, Pellicori, Pierpaolo ORCID: https://orcid.org/0000-0001-7175-0464, Rigby, Alan S. and Clark, Andrew L. (2022) Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure. ESC Heart Failure, 9(5), pp. 3009-3018. (doi: 10.1002/ehf2.14028) (PMID:35736536) (PMCID:PMC9715820)

Dubé, M.‐P. et al. (2022) Pharmacogenomic study of heart failure and candesartan response from the CHARM programme. ESC Heart Failure, 9(5), pp. 2997-3008. (doi: 10.1002/ehf2.14026) (PMID:35736394) (PMCID:PMC9715825)

Ferreira, João Pedro, Claggett, Brian L., Docherty, Kieran F. ORCID: https://orcid.org/0000-0002-5446-9969, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Zannad, Faiez, Solomon, Scott D. and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2022) Within trial comparison of survival time projections from short-term follow-up with long-term follow-up findings. ESC Heart Failure, 9(5), pp. 3655-3658. (doi: 10.1002/ehf2.13731) (PMID:35799450) (PMCID:PMC9715817)

Savarese, G. et al. (2022) Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction. ESC Heart Failure, 9(4), pp. 2107-2118. (doi: 10.1002/ehf2.13917) (PMID:35388650) (PMCID:PMC9288797)

Austin, Rosalynn C., Schoonhoven, Lisette, Koutra, Vasiliki, Richardson, Alison, Kalra, Paul R. and May, Carl R. (2022) SYMptoms in chronic heart failure imPACT on burden of treatment (SYMPACT): a cross‐sectional survey. ESC Heart Failure, 9(4), pp. 2279-2290. (doi: 10.1002/ehf2.13904) (PMID:35451208) (PMCID:PMC9288776)

Jorbendaze, A. et al. (2022) Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first‐in‐patient study. ESC Heart Failure, 9(4), pp. 2207-2214. (doi: 10.1002/ehf2.13984) (PMID:35619238) (PMCID:PMC9288796)

Girerd, N. et al. (2022) Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Failure, 9(4), pp. 2063-2069. (doi: 10.1002/ehf2.13929) (PMID:35429120) (PMCID:PMC9288781)

Halliday, B. P. et al. (2022) Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy. ESC Heart Failure, 9(3), pp. 1616-1624. (doi: 10.1002/ehf2.13872) (PMID:35257498) (PMCID:PMC9065828)

Goldberg, Lee R., Jorbenadze, Ana, Shaburishvilli, Tamaz, Mirro, Michael J., Fudim, Marat, Zuber, Michel, Stämpfli, Simon F., Tanner, Felix C., Erne, Paul and Cleland, John G. ORCID: https://orcid.org/0000-0002-1471-7016 (2022) Synchronized diaphragmatic stimulation: a case report of a novel extra-cardiac intervention for chronic heart failure. ESC Heart Failure, 9(3), pp. 1677-1681. (doi: 10.1002/ehf2.13882) (PMID:35297198) (PMCID:PMC9065831)

Wei, D. et al. (2022) The novel proteomic signature for cardiac allograft vasculopathy. ESC Heart Failure, 9(2), pp. 1216-1227. (doi: 10.1002/ehf2.13796) (PMID:35005846) (PMCID:PMC8934921)

Mujaj, B. et al. (2022) Aspirin use is associated with increased risk for incident heart failure: a patient-level pooled analysis. ESC Heart Failure, 9(1), pp. 685-694. (doi: 10.1002/ehf2.13688) (PMID:34808706) (PMCID:PMC8787993)

Deis, T. et al. (2022) Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction. ESC Heart Failure, 9(1), pp. 186-195. (doi: 10.1002/ehf2.13697) (PMID:34877822) (PMCID:PMC8788022)

Lumbers, R. T. et al. (2021) The genomics of heart failure: design and rationale of the HERMES consortium. ESC Heart Failure, 8(6), pp. 5531-5541. (doi: 10.1002/ehf2.13517) (PMID:34480422) (PMCID:PMC8712846)

Diamant, Michael J., Andrade, Jason G., Virani, Sean A., Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and Hawkins, Nathaniel M. (2021) Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Failure, 8(6), pp. 4484-4496. (doi: 10.1002/ehf2.13526) (PMID:34505352) (PMCID:PMC8712920)

Shah, Parin, Abel, Alexandra A.I., Boyalla, Vennela, Pellicori, Pierpaolo ORCID: https://orcid.org/0000-0001-7175-0464, Kallvikbacka-Bennett, Anna, Sze, Shirley, Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016 and Clark, Andrew L. (2021) A comparison of non-invasive methods of measuring body composition in patients with heart failure: a report from SICA-HF. ESC Heart Failure, 8(5), pp. 3929-3934. (doi: 10.1002/ehf2.13402) (PMID:34216106) (PMCID:PMC8497207)

Raafs, A. et al. (2021) Identification of sex‐specific biomarkers predicting new‐onset heart failure. ESC Heart Failure, 8(5), pp. 3512-3520. (doi: 10.1002/ehf2.13476) (PMID:34156155) (PMCID:PMC8497379)

Gardner, Roy S., Capodilupo, Robert C., Ahmed, Rezwan, Stolen, Craig M., An, Qi, Averina, Viktoria, Hernandez, Adrian F. and Boehmer, John P. (2021) Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS‐CoV‐2 infection. ESC Heart Failure, 8(5), pp. 4026-4036. (doi: 10.1002/ehf2.13500) (PMID:34184428) (PMCID:PMC8426935)

Papageorgiou, Vasiliki, Jones, Kathryn, Halliday, Brian P., Mindham, Richard, Bruton, Jane, Wassall, Rebecca, Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016, Prasad, Sanjay K. and Ward, Helen (2021) A qualitative exploration of participant and investigator perspectives from the TRED-HF trial. ESC Heart Failure, 8(5), pp. 3760-3768. (doi: 10.1002/ehf2.13524) (PMID:34390213) (PMCID:PMC8497205)

Jorbenadze, Ana, Fudim, Marat, Mahfoud, Felix, Adamson, Phillip B., Bekfani, Tarek, Wachter, Rolf, Sievert, Horst, Ponikowski, Piotr P., Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016 and Anker, Stefan D. (2021) Extra-cardiac targets in the management of cardiometabolic disease: device-based therapies. ESC Heart Failure, 8(4), pp. 3327-3338. (doi: 10.1002/ehf2.13361) (PMID:34002946) (PMCID:PMC8318435)

Espersen, C. et al. (2021) Sex differences in congestive markers in patients hospitalized for acute heart failure. ESC Heart Failure, 8(3), pp. 1784-1795. (doi: 10.1002/ehf2.13300) (PMID:33709520) (PMCID:PMC8120385)

Mbakwem, A. C. et al. (2021) Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. ESC Heart Failure, 8(2), pp. 879-889. (doi: 10.1002/ehf2.13172) (PMID:33453082) (PMCID:PMC8006717)

Docherty, K. F. et al. (2021) Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling. ESC Heart Failure, 8(1), pp. 129-138. (doi: 10.1002/ehf2.13137) (PMID:33305513) (PMCID:PMC7835504)

Pellicori, Pierpaolo ORCID: https://orcid.org/0000-0001-7175-0464, Ofstad, Anne Pernille, Fitchett, David, Zeller, Cordula, Wanner, Christoph, George, Jyothis, Zinman, Bernard, Brueckmann, Martina and Lindenfeld, JoAnn (2020) Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME. ESC Heart Failure, 7(6), pp. 3401-3407. (doi: 10.1002/ehf2.12891) (PMID:32915523) (PMCID:PMC7754994)

Austin, Rosalynn C, Schoonhoven, Lisette, Richardson, Alison, Kalra, Paul R. and May, Carl R (2020) How do SYMPtoms and management tasks in chronic heart failure imPACT a person's life (SYMPACT)? Protocol for a mixed-methods study. ESC Heart Failure, 7(6), pp. 4472-4477. (doi: 10.1002/ehf2.13010) (PMID:32940966) (PMCID:PMC7754908)

Yeoh, S. E. et al. (2020) Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF. ESC Heart Failure, 7(6), pp. 3355-3364. (doi: 10.1002/ehf2.12972) (PMID:33078584) (PMCID:PMC7754973)

Campbell, R. T. et al. (2020) The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure. ESC Heart Failure, 7(4), pp. 1595-1604. (doi: 10.1002/ehf2.12708) (PMID:32383555) (PMCID:PMC7373887)

Brainin, P. et al. (2020) Body mass index and B-lines on lung ultrasonography in chronic and acute heart failure. ESC Heart Failure, 7(3), pp. 1201-1209. (doi: 10.1002/ehf2.12640) (PMID:32077268) (PMCID:PMC7261588)

Bouabdallaoui, Nadia, O'Meara, Eileen, Bernier, Virginie, Komajda, Michel, Swedberg, Karl, Tavazzi, Luigi, Borer, Jeffrey S., Bohm, Michael, Ford, Ian ORCID: https://orcid.org/0000-0001-5927-1823 and Tardif, Jean‐Claude (2019) Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m. ESC Heart Failure, 6(6), pp. 1199-1207. (doi: 10.1002/ehf2.12513) (PMID:31591826) (PMCID:PMC6989297)

Johnson, M. J. et al. (2019) Oral modified release morphine for breathlessness in chronic heart failure: a randomised placebo-controlled trial. ESC Heart Failure, 6(6), pp. 1149-1160. (doi: 10.1002/ehf2.12498) (PMID:31389157) (PMCID:PMC6989293)

Kaye, D. M. et al. (2019) Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Failure, 6(1), pp. 62-69. (doi: 10.1002/ehf2.12350) (PMID:30311437) (PMCID:PMC6351895)

Ramires, F. J.A. et al. (2018) Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al. ESC Heart Failure, 5(6), pp. 1069-1071. (doi: 10.1002/ehf2.12355) (PMID:30298996) (PMCID:PMC6300803)

Keene, D. et al. (2018) Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial. ESC Heart Failure, 5(5), pp. 965-976. (doi: 10.1002/ehf2.12315) (PMID:29984912) (PMCID:PMC6165934)

Ueland, Thor, Gullestad, Lars, Kou, Lei, Aukrust, Pål, Anand, Inderjit S., Broughton, Marianne Nordlund, McMurray, John J. ORCID: https://orcid.org/0000-0002-6317-3975, van Veldhuisen, Dirk J., Warren, David J. and Bolstad, Nils (2018) Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study. ESC Heart Failure, 5(6), pp. 1052-1059. (doi: 10.1002/ehf2.12312) (PMID:30145817) (PMCID:PMC6300802)

Osmanska, Joanna, Hawkins, Nathaniel M., Toma, Mustafa, Ignaszewski, Andrew and Virani, Sean A. (2018) Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure. ESC Heart Failure, 5(4), pp. 668-674. (doi: 10.1002/ehf2.12297) (PMID:29938922) (PMCID:PMC6073034)

Høydal, M. A. et al. (2018) Human cardiomyocyte calcium handling and transverse tubules in mid-stage of post-myocardial-infarction heart failure. ESC Heart Failure, 5(3), pp. 332-342. (doi: 10.1002/ehf2.12271) (PMID:29431258) (PMCID:PMC5933953)

Gastelurrutia, Paloma, Lupón, Josep, Domingo, Mar, Stut, Wim, Dovancescu, Silviu, Cleland, John ORCID: https://orcid.org/0000-0002-1471-7016, Frankenstein, Lutz and Bayes-Genis, Antoni (2017) Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme. ESC Heart Failure, 4(1), pp. 66-70. (doi: 10.1002/ehf2.12104) (PMID:28217314) (PMCID:PMC5292630)

Zhang, Jufen, Dierckx, Riet, Mohee, Kevin, Clark, Andrew L. and Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016 (2017) Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Failure, 4(1), pp. 40-45. (doi: 10.1002/ehf2.12112) (PMID:28217311) (PMCID:PMC5292634)

Campbell, R. T. et al. (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Failure, 2(1), pp. 25-36. (doi: 10.1002/ehf2.12027) (PMID:27347426) (PMCID:PMC4864752)